Compare NKE & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKE | ELV |
|---|---|---|
| Founded | 1964 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.5B | 85.7B |
| IPO Year | 1995 | 2001 |
| Metric | NKE | ELV |
|---|---|---|
| Price | $40.52 | $391.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 19 |
| Target Price | $63.44 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 19.4M | 1.6M |
| Earning Date | 03-31-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.69% | 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.38 | ★ 8.00 |
| Revenue | $46,309,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $0.91 | N/A |
| Revenue Next Year | $0.56 | $3.07 |
| P/E Ratio | ★ $29.55 | $48.39 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $40.44 | $273.71 |
| 52 Week High | $80.17 | $426.98 |
| Indicator | NKE | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 34.61 | 49.58 |
| Support Level | N/A | $384.30 |
| Resistance Level | $46.98 | $408.00 |
| Average True Range (ATR) | 1.39 | 10.68 |
| MACD | -0.42 | -3.36 |
| Stochastic Oscillator | 9.59 | 22.18 |
Nike is the largest athletic footwear and apparel brand in the world. Footwear generates about two-thirds of its sales. Key performance footwear categories include basketball, running, and football (soccer). Its brands include Nike, Jordan (premium athletic footwear and clothing), NikeSkims (women's athleisure), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores (including about 5,500 in China), and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.